EXTRACELLULAR VESICLE-BASED NON-INVASIVE DETECTION OF PIK3CA COMPOUND MUTATION FOR BREAST CANCER

$562,500FY2022Defense Health AgencyDOD

Captis Diagnostics Inc.

Investigators